BUSINESS
Fed vs. Trumponomics 2.0: Post rate cut, how should investors position themselves?
Initially, the US central bank will respond primarily to the non-farm payroll trajectory. But later on, any aggressive stance by Trump on global trade, the fiscal deficit and immigration can potentially rekindle inflation
BUSINESS
Sagility IPO: A play on US healthcare outsourcing market
Balance sheet healthy and there is room to raise more funds in future
BUSINESS
Ami Organics: Early CDMO ramp-up aces growth outlook
While the semi-conductor and battery chemical businesses are the new drivers of growth for the long term, it would take time. Near-term growth would be driven by the advanced intermediates business.
BUSINESS
Dabur: A bigger rural footprint, a wider product basket key growth levers
Urban demand has bottomed out and expected to pick up once food inflation stabilises
BUSINESS
Cipla: M&A positioning, new US regime are key wild cards
The management is primarily focusing on Indian assets which can bring synergy, followed by US assets. Cipla’s continued investment in US subsidiary InvaGen would de-risk the business model from a compliance point of view.
BUSINESS
Syngene: FY25 guidance intact as biotech funding revives
The macro tailwinds are strong as biotech firms are looking for a China alternative and the US Biotech Act can potentially decouple China’s biotech supply chain from the US biotech value chain
BUSINESS
Navin Fluorine: Strong order book visibility for CDMO, specialty segments
The capex projects for agro-specialty at Dahej, the additional R-32 capacity, and the anhydrous hydrofluoric acid plants should also contribute to FY26 earnings
BUSINESS
Himadri Speciality: Little comfort on valuation
In the near term, HSCL could continue to benefit from the demand-supply mismatch in Europe. HSCL’s long-term plan is to diversify into new-age businesses. This can have a long gestation period and face technological challenges
BUSINESS
Nestle India: Sluggish consumption amid elevated commodity prices
Coffee and cocoa were particularly costlier while prices of cereals and edible oils picked up due to an erratic monsoon
BUSINESS
Reliance Industries Q2: Consumption-oriented segments telecom, retail drive growth
While a subdued global economic environment has affected its O2C business performance, improving prospects for consumption growth and progress in new energy business will drive the stock outlook
BUSINESS
Trump vs Harris: What it means for India and markets
A Republican win could be negative for EMs, while a Democrat victory is likely to be beneficial for countries like India
BUSINESS
How prudent is the investment case for HEG?
The graphite electrode player is likely to be a key beneficiary of the decarbonisation trend in the steel industry
BUSINESS
As the Middle East explodes, how should investors position themselves?
Valuation makes the Indian market vulnerable to a military escalation. The gap between Nifty earnings yield and the 10-year G-Sec yield is closer to the average during historical market peaks
BUSINESS
What should investors do with these carbon-black twins?
Long-term plans have a long gestation period and can face challenges
BUSINESS
Nocil: A casualty of China dumping
The current challenges due to dumping and moderate growth expectations are a dampener. Further, elevated valuation is likely to cap the upside in the near term
BUSINESS
Fed’s aggressive defence: What should investors do?
The US Fed’s rate cut cycle will reinforce the gush of liquidity to Indian markets, which, along with earnings growth, should continue to offset valuation concerns in the near term.
BUSINESS
Tarsons Products: Industry indicators point to recovery
Upcoming capacities, plans to unveil new products, and an inorganic strategy to push exports should drive earnings growth in the near to medium term
BUSINESS
What’s the importance of US Biosecure Act for India?
The legislation will curb the dominance of Chinese players in the US biotech industry, throwing up opportunities for Indian companies
BUSINESS
Ami Organics: Well placed to meet growth guidance despite global challenges
Successful inspection by the regulatory agency of Japan adds to the company’s credential in the advanced intermediates space
BUSINESS
Concord Biotech: Strong grip on fermentation APIs stays
Though valuations are at a premium, the company has strong earnings prospects ahead
BUSINESS
Jackson Hole Symposium: The interest rate cycle's direction is clear
Stock portfolio churn could be tricky as Fed takes cues from high-frequency indicators and starts cutting rates for better risk-reward balance
BUSINESS
Balaji Amines: What is the future of this import substitution play?
The medium-term growth driver is a series of projects, which are getting commissioned in the near term. Also, the company has a significant surplus capacity that can gain traction from a gradual global recovery.
BUSINESS
Galaxy Surfactants: Growth led by advanced economies
The domestic market is cautiously growing after a strong FY24 and the economy is improving. Logistics pose a key challenge for the company
BUSINESS
Aarti Industries: Greedy when others are fearful?
As the volume growth guidance is intact and new capacities and newer chemical value chains are expected to get unlocked in the next two years, investors should consider the opportunity the market is offering
